
1. General Information
Humalog KwikPen 100 IU/3 mL contains insulin lispro, a rapid-acting insulin analogue. It is designed to help control blood glucose levels in people with diabetes mellitus. The 3 mL U-100 KwikPen contains a total of 300 units of insulin lispro.
Humalog is generally used around mealtimes because insulin lispro starts working rapidly. The dose and treatment schedule should be individualized by a qualified healthcare professional according to blood-glucose levels, dietary intake, activity, and other medical factors.
Phoenix Exim, a medicine exporter from Nagpur, India, supplies pharmaceutical products for international markets, subject to applicable prescription, import, and regulatory requirements in the destination country.
2. Product Information
Brand: Humalog KwikPen
Active ingredient: Insulin lispro
Strength: 100 units/mL (U-100)
Pen volume: 3 mL
Total insulin per pen: 300 units
Dosage form: Injectable solution
Type: Rapid-acting insulin analogue
Route: Primarily subcutaneous injection
Manufacturer/brand owner: Eli Lilly and Company
Presentation: Single-patient-use prefilled KwikPen
The Humalog KwikPen dose window displays the number of insulin units to be administered, so users should not perform their own dose conversion when using the prefilled pen.
3. Uses of Humalog KwikPen
Humalog (insulin lispro) is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.
It may be prescribed as part of an individualized diabetes-management plan for:
Type 1 diabetes
Type 2 diabetes when insulin treatment is required
Mealtime blood-glucose control
Management of elevated blood glucose as directed by a healthcare professional
The exact insulin regimen depends on the patient's individual requirements and may be used alongside longer-acting or intermediate-acting insulin when prescribed.
4. Benefits of Humalog KwikPen
Potential benefits when prescribed and used correctly include:
Helps lower elevated blood glucose levels.
Provides rapid-acting insulin coverage around meals.
Helps improve overall glycemic control.
The prefilled pen provides a convenient delivery format.
The dose window allows the selected insulin dose to be viewed directly.
Each KwikPen contains 300 units of insulin lispro and can provide multiple doses.
Humalog should be considered one component of an overall diabetes-management plan that may include diet, physical activity, glucose monitoring, and other medicines.
5. Side Effects of Humalog KwikPen
The most important potential adverse effect of insulin treatment is hypoglycemia (low blood glucose). Severe hypoglycemia can be dangerous and requires prompt treatment.
Other possible adverse effects can include:
Injection-site reactions
Lipodystrophy or changes in the fatty tissue at injection sites
Localized cutaneous amyloidosis
Allergic reactions or hypersensitivity
Weight gain
Edema
Low potassium levels in certain circumstances
Insulin requirements can change with meals, physical activity, illness, and kidney or liver function, so dose adjustments may sometimes be necessary under medical supervision.
6. Common Side Effects
Possible commonly encountered effects include:
Low blood sugar
Injection-site redness, swelling, itching, or discomfort
Changes in the skin or fatty tissue where injections are repeatedly administered
Weight gain
Swelling of the hands or feet
Not every patient experiences these effects. Persistent, severe, or unusual symptoms should be discussed with a healthcare professional.
7. How to Use Humalog KwikPen
Humalog KwikPen should be used exactly according to the instructions provided by the prescribing healthcare professional and the product's Instructions for Use.
General administration principles include:
Check the medicine and pen before use.
Use a new compatible pen needle for each injection.
Confirm the prescribed dose using the pen's dose window.
Humalog U-100 is generally injected subcutaneously.
Typical injection sites include the abdomen, thigh, upper arm, or buttocks.
Rotate injection sites to reduce the risk of tissue changes.
Humalog may be administered within 15 minutes before a meal or immediately after a meal, according to the prescribing information.
Follow the healthcare professional's instructions regarding blood-glucose monitoring and dose adjustment.
Never share the KwikPen with another person, even if the needle has been changed.
Do not change the insulin dose or timing without medical advice.
8. How Humalog KwikPen Works
Humalog contains insulin lispro, which is structurally modified from human insulin to produce rapid insulin action.
After subcutaneous administration, insulin lispro helps the body's cells take up glucose from the bloodstream and helps reduce glucose production by the liver. This lowers blood glucose and helps improve glycemic control.
Because it is a rapid-acting insulin, it is particularly useful for managing glucose associated with meals. The timing and duration of action can vary between individuals.
9. Safety Advice
Use Humalog only according to a healthcare professional's prescription.
Do not use insulin lispro during an episode of hypoglycemia.
Monitor blood glucose as recommended.
Learn to recognize symptoms of low blood sugar, such as sweating, shaking, hunger, dizziness, confusion, or rapid heartbeat.
Carry an appropriate source of rapidly absorbable glucose if advised by your diabetes-care team.
Never share a pen or needle.
Rotate injection sites.
Do not use the product if you are allergic to insulin lispro or any of its ingredients.
Tell your healthcare professional about other medicines you take because some medicines can affect blood-glucose levels or insulin requirements.
Insulin requirements may change during illness, changes in physical activity, changes in meal patterns, or changes in kidney or liver function.
Intravenous administration of insulin lispro should only be performed under appropriate medical supervision with glucose and potassium monitoring.
Keep the product stored according to the manufacturer's current storage instructions and protect it from inappropriate temperatures, light, and freezing.
Seek urgent medical attention for severe hypoglycemia, severe allergic reactions, loss of consciousness, or other serious symptoms.
Important: Insulin is a prescription medicine. Patients should not substitute one insulin product for another or independently change insulin doses.
10. Frequently Asked Questions (FAQs)
Q1. What is Humalog KwikPen 100 IU/3 mL?
Humalog KwikPen is a prefilled insulin pen containing insulin lispro 100 units/mL. Each 3 mL pen contains 300 units of insulin.
Q2. What is Humalog used for?
It is used to improve blood-glucose control in adults and children with diabetes mellitus.
Q3. Is Humalog a rapid-acting insulin?
Yes. Insulin lispro is classified as a rapid-acting insulin analogue.
Q4. When is Humalog usually taken?
For subcutaneous administration, Humalog U-100 may generally be administered within 15 minutes before a meal or immediately after a meal, according to the prescribing information.
Q5. How many units are in one Humalog KwikPen?
A 3 mL U-100 KwikPen contains 300 units of insulin lispro.
Q6. Can Humalog KwikPen be shared?
No. The pen is intended for single-patient use and must not be shared, even when a new needle is used.
Q7. What happens if blood sugar becomes too low?
Low blood sugar can be a serious adverse effect of insulin therapy. Follow the hypoglycemia treatment plan provided by your healthcare professional and seek emergency assistance for severe symptoms.
Q8. Can I change from Humalog to another insulin myself?
No. Different insulin products may have different properties, concentrations, and dosing requirements. Switching should be performed under medical supervision.
Q9. Can Humalog be used in children?
Humalog is indicated to improve glycemic control in pediatric patients as well as adults, although the appropriate regimen must be determined by the child's healthcare professional.
Q10. Is Humalog KwikPen available for international supply?
Availability, prescription requirements, import rules, and registration requirements vary by country. International supply should comply with the regulations of the destination market.
11. Substitute for Humalog KwikPen
Potential alternatives belong to the rapid-acting insulin category, but a substitute should be selected by a healthcare professional rather than chosen solely by brand name.
Depending on the patient's clinical requirements and local availability, healthcare professionals may consider products containing:
Insulin aspart
Insulin glulisine
Other appropriate insulin lispro presentations
Examples of rapid-acting insulin brands may include NovoLog/NovoRapid (insulin aspart) and Apidra (insulin glulisine), depending on the country.
These products are not automatically dose-for-dose interchangeable. The appropriate product, concentration, timing, and dosage should be determined by the treating healthcare professional.
12. SEO Keywords
Primary Keywords
Humalog KwikPen 100 IU 3 mL
Humalog KwikPen 100 units/mL
Humalog insulin lispro
Insulin lispro injection
Humalog KwikPen supplier
Humalog KwikPen exporter from India
Insulin lispro exporter India
Humalog KwikPen pharmaceutical exporter
Humalog insulin supplier India
Humalog KwikPen medicine exporter
B2B / Export Keywords
Humalog KwikPen exporter from Nagpur India
insulin lispro exporter from India
Humalog KwikPen wholesale supplier India
insulin lispro wholesale exporter
Humalog KwikPen international supplier
pharmaceutical exporter from Nagpur India
diabetes medicine exporter India
insulin medicine supplier India
Humalog KwikPen export supplier
insulin lispro pharmaceutical supplier
Country-Focused Keywords
Humalog KwikPen exporter to USA
Humalog KwikPen exporter to UK
Humalog KwikPen exporter to Australia
Humalog KwikPen exporter to Singapore
Humalog KwikPen exporter to Canada
Humalog KwikPen exporter to South Korea
Humalog KwikPen exporter to UAE
insulin lispro exporter to USA
insulin lispro exporter to UK
insulin lispro exporter to Australia
insulin lispro exporter to Canada
insulin lispro supplier for international markets
Keywords







